Chile approves emergency use of Oxford-AstraZeneca COVID-19 vaccine - World News sina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com Daily Mail and Mail on Sunday newspapers.
Aislinn Laing, Natalia A. Ramos Miranda
3 分钟阅读
(Adds timeline for AZ roll out, COVAX)
SANTIAGO, Jan 27 (Reuters) - Chile’s health regulator on Wednesday approved the AstraZeneca-Oxford COVID-19 vaccine for emergency use among its population by a unanimous vote of its advisory board.
The approval from the Chilean Public Health Institute (ISP) is for the use of 6.6 million doses as part of a two-dose regime for Chileans over the age of 18 and without an upper age limit.
Chilean trade vice-minister Rodrigo Yanez, in charge of vaccine supply agreements, said four million doses that had been purchased direct from the company would start to arrive at the end of March and be administered until June.
By Aislinn Laing and Natalia A. Ramos Miranda
SANTIAGO, Jan 27 (Reuters) - Chile s health regulator on Wednesday approved the AstraZeneca-Oxford COVID-19 vaccine for emergency use among its population by a unanimous vote of its advisory board.
The approval from the Chilean Public Health Institute (ISP) is for the use of 6.6 million doses as part of a two-dose regime for Chileans over the age of 18 and without an upper age limit.
Chilean trade vice-minister Rodrigo Yanez, in charge of vaccine supply agreements, said four million doses that had been purchased direct from the company would start to arrive at the end of March and be administered until June.
UPDATE 2-Chile health regulator approves AstraZeneca COVID-19 vaccine for emergency use Reuters 1/27/2021
(Adds timeline for AZ roll out, COVAX)
By Aislinn Laing and Natalia A. Ramos Miranda
SANTIAGO, Jan 27 (Reuters) - Chile s health regulator on Wednesday approved the AstraZeneca-Oxford COVID-19 vaccine for emergency use among its population by a unanimous vote of its advisory board.
The approval from the Chilean Public Health Institute (ISP) is for the use of 6.6 million doses as part of a two-dose regime for Chileans over the age of 18 and without an upper age limit.
Chilean trade vice-minister Rodrigo Yanez, in charge of vaccine supply agreements, said four million doses that had been purchased direct from the company would start to arrive at the end of March and be administered until June.